Millie
your market intelligence analyst
Search Results
Edit Save
10,135 results
Visual and Refractive Long-Term Outcomes Following Standard Cross-Linking in Progressive Keratoconus Management Mohammed Iqbal,1 Ahmed Elmassry,2 Amani E Badawi,3 Hesham M Gharieb,4 Omar M Said5 1Department of Ophthalmology, Faculty of Medicine, Sohag University, Sohag, Egypt; 2Department of Ophthalmology, Faculty of Medicine, Alexandria University, Alexandria, Egypt; 3Department of Ophthalmology, Faculty of Medicine, Mansoura University, Mansoura, Egypt; 4Department of Ophthalmology, Faculty of Medicine, Ain Shams University, Cairo, Egypt; 5Department of Ophthalmology, Faculty of Medicine, Fayoum University, Fayoum, EgyptCorrespondence: Omar M SaidDepartment of Ophthalmology, Faculty of Medicine, Fayoum University, Fayoum, EgyptTel +20 100.
Association Between Biofilm Formation, Structure, and the Expression Levels of Genes Related to biofilm formation and Biofilm-Specific Resistance of Acinetobacter baumannii Strains Isolated from Burn Infection in Ahvaz, Iran Mansour Amin,1,2 Tahereh Navidifar,2,3 Farkhondeh Saleh Shooshtari,2,4 Mohammad Rashno,3,5 Mohammad Savari,1,2 Fatemeh Jahangirmehr,6 Mania Arshadi1 1Infectious and Tropical Diseases Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran; 2Department of Microbiology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran; 3Cellular and Molecular Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran; 4Infertility Resear.
Heterozygous Disruption of Beclin 1 Alleviates Zinc Oxide Nanoparticles-Induced Disturbance of Cholesterol Biosynthesis in Mouse Liver Xuemei Liu,1,* Bin Wang,2,* Xuejun Jiang,3 Jun Zhang,2 Qianghu Tang,1 Yujia Zhang,1 Xia Qin,4 Chengzhi Chen,1,5 Zhen Zou2,5 1Department of Occupational and Environmental Health, School of Public Health and Management, Chongqing Medical University, Chongqing 400016, People’s Republic of China; 2Institute of Life Sciences, Chongqing Medical University, Chongqing 400016, People’s Republic of China; 3Center of Experimental Teaching for Public Health, Experimental Teaching and Management Center, Chongqing Medical University, Chongqing 400016, People’s Republic of China; 4Department of Pharmacy, The First Affiliat.
Relationship Between Skeletal Muscle Mass Indexes and Muscular Function, Metabolic Profile and Bone Mineral Density in Women with Recommendation for Bariatric Surgery Nara Nóbrega Crispim Carvalho,1,2 Vinícius José Baccin Martins,3 João Modesto Filho,2 Francisco Bandeira,4 Flávia Cristina Fernandes Pimenta,5 José Luiz de Brito Alves1 1Department of Nutrition, Health Sciences Center, Federal University of Paraiba, Joao Pessoa, Brazil; 2Department of Endocrinology, Lauro Wanderley University Hospital, Federal University of Paraiba, Joao Pessoa, Brazil; 3Department of Physiology and Pathology, Federal University of Paraiba, Joao Pessoa, Brazil; 4Division of Diabetes and Endocrinology of Agamenon Magalhães Hospital, Recife, Brazil; 5Lauro Wande.
Triterpenoid Saponins from Anemone flaccida Suppress Tumor Cell Proliferation by Regulating MAPK, PD1/PDL1, and STAT3 Signaling Pathways and Altering Cancer Metabolism Lintao Han,1 Shiqi Yao,2 Sa Cao,2 Guoyan Mo,1 Jingjing Li,1 Yan Cao,2 Fang Huang1 1Key Laboratory of Traditional Chinese Medicine Resource and Prescription, Ministry of Education, Wuhan, Hubei 430061, People’s Republic of China; 2College of Pharmacy, Hubei University of Chinese Medicine, Wuhan, Hubei 430065, People’s Republic of ChinaCorrespondence: Yan CaoCollege of Pharmacy, Hubei University of Chinese Medicine, No. 1 Huang-Jia-Hu Road, Wuhan, Hubei 430065, People’s Republic of ChinaTel/Fax +86 27 68896121Email 458425708@qq.comFang HuangKey Laboratory of Traditional Chinese.
Clinical Improvements as Predictors of Improvements in Patient-Reported Outcomes: Post Hoc Analysis of a Randomized, Open-Label Study of Etanercept in Latin American Patients with Rheumatoid Arthritis Generoso Guerra Bautista,1 Ricardo Machado Xavier,2 Maria de la Vega,3 J Abraham Simón-Campos,4 Gastón Solano,5 Ronald D Pedersen,6 Bonnie Vlahos,6 Cecilia Borlenghi7 1Centro de Investigación Marbella, Paitilla Panamá, Panamá; 2Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil; 3CEIM Investigaciones Medicas, Buenos Aires, Argentina; 4Köhler & Milstein Research, Mérida, México; 5Pfizer, San José, Costa Rica; 6Pfizer, Collegeville, PA, USA; 7Pfizer, Buenos Aires, ArgentinaCorrespondence: Generoso Guerra BautistaConsultorios Royal Center.
Drug-Drug Interactions Of Amiodarone And Quinidine On The Pharmacokinetics Of Eliglustat In Rats Qiong Wang,1 Haiyun Wang,1 Youyan Zhong,1 Qiang Zhang2 1Department of Pharmacy, Wenzhou People’s Hospital, Wenzhou, Zhejiang 325000, People’s Republic of China; 2Department of Clinical Laboratory, The People’s Hospital of Lishui, Lishui, Zhejiang 323000, People’s Republic of ChinaCorrespondence: Qiang ZhangDepartment of Clinical Laboratory, The People’s Hospital of Lishui, Lishui, Zhejiang 323000, People’s Republic of ChinaEmail zhangqianglsrmyy@sina.comBackground: Eliglustat, a new oral substrate-reduction therapy, was recently approved as a first-line therapy for Gaucher’s disease type 1 (GD1) patients.Purpose: The purpose of the present study.

Automotive Industries

Business Issues

Companies - Public

Companies - Venture Funded

Global Markets

Government Agencies

Information Technologies

Job Titles

Legal and Regulatory

Market Research Topics

Political Entities

Sources

Strategic Scenarios

Trends